Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Ocean Biomedical Inc (OCEA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Ocean Biomedical's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.400 -0.105    -6.98%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
1.450
+0.050
+3.571%
0:46:55 - Real-time Data
  • Volume: 305,077
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.330 - 1.550
Type:  Equity
Market:  United States
Ocean Biomedical 1.400 -0.105 -6.98%

Ocean Biomedical Company Profile

 
Read the Ocean Biomedical Inc company profile to learn more about the business and the management team. View Ocean Biomedical Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.

Contact Information

Address Room 325, 55 Claverick Street
Providence, 02903
United States
Phone 401 444 7375
Fax -

Top Executives

Name Age Since Title
William Forrester Owens 73 2021 Independent Director
Elizabeth Ng 66 2019 CEO & Director
Martin David Angle 73 2021 Independent Director
Bethany Solomon - - Member of Advisory Board
Erol Fikrig - - Member of Scientific Advisory Board
M. Michelle Berrey 56 2021 Independent Director
William H. Koster 79 - Member of Scientific Advisory Board
Jackie Ernst - - Member of Advisory Board
Wafik El-Deiry - - Member of Scientific Advisory Board
Jane Halpern - 2021 Member of Advisory Board
Roy Steven Herbst 60 - Member of Scientific Advisory Board
Jeff Tepper - 2021 Member of Advisory Board - Preclinical Safety
Surendra K. Ajjarapu 52 2021 Director
Michael L. Peterson 61 2021 Independent Director
Jack A. Elias 73 - Founder, Chairman of Scientific Advisory Board & Independent Director
Chirinjeev Baboo Kathuria 59 2019 Founder & Executive Chairman of the Board
Jonathan Kurtis 55 2021 Founder, Chairman of Scientific Advisory Board & Director
Amy E. Griffith 51 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCEA Price Commentary

Write your thoughts about Ocean Biomedical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email